-15% New

Nefiracetam 100mg (60 capsules)

Original price was: 40,99 €.Current price is: 34,84 €.

Find out what benefits peptides have

Discover how peptides can boost recovery, improve skin health, increase energy and support overall performance. Explained simply and clearly in this short video.

Product Description

Research Compound · Capsules

Nefiracetam 100 mg – 60 Capsules

Research-grade compound supplied as 60 pre-portioned capsules, each containing 100 mg nefiracetam (DM-9384). A 2-pyrrolidinone-derivative compound of the racetam class, studied in controlled experimental models of cholinergic and glutamatergic pharmacology, GABA-A modulation, and L-type calcium-channel activity.

Research Use Only

This product is intended strictly for laboratory and scientific investigation. Not for human consumption, therapeutic use, or veterinary application.

Specifications

Purity

≥99% (HPLC, third-party tested, CoA on file)

Form

Research capsules

Content per Capsule

100 mg nefiracetam

Total per Bottle

60 capsules (6 g total)

Packaging

Sealed bottle with tamper-evident closure

Storage

Store at room temperature, dry, protected from light

Molecular Formula

C₁₄H₁₈N₂O₂

Molecular Weight

≈ 246.31 g/mol

IUPAC Name

N-(2,6-dimethylphenyl)-2-(2-oxopyrrolidin-1-yl)acetamide

CAS Number

77191-36-7

Format

Supplied as pre-portioned research capsules — no reconstitution or weighing is required, supporting consistent dosing accuracy in controlled experimental workflows. Keep the bottle sealed and stored at room temperature, dry and protected from light.

Research Overview

Nefiracetam (DM-9384) is a 2-pyrrolidinone-derivative compound of the racetam class developed in Japan in the 1980s. Mechanistically, it combines the canonical racetam pro-cholinergic profile (enhancement of high-affinity choline uptake and acetylcholine release) and pro-glutamatergic profile (NMDA-receptor potentiation) with two distinctive additional mechanisms: positive allosteric modulation of GABA-A receptors and direct enhancement of L-type voltage-gated calcium-channel activity in hippocampal neurons. In controlled experimental settings it is used as a reference compound in cognition and synaptic-plasticity research. No therapeutic or clinical claims are made or implied.